Current methods for measuring the glomerular filtration rate in persons with normal weight and overweight


Cite item

Full Text

Abstract

A steady increase in glomerular filtration rate is considered to be one of the first stages of renal lesion in essential hypertension, metabolic syndrome, and type 2 diabetes mellitus. The paper discusses methods for detection of hyperfiltration and gives their comparative characterization and indications for their use.

References

  1. Wahba I. M., Mak R. H. Obesity and obesity-initiated metabolic syndrome: Mechanistic links to chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2007; 2: 550-562.
  2. Labib M. The investigation and management of obesity. J. Clin. Pathol. 2003; 56: 17-25.
  3. Ford E. S., Giles W. H., Dietz W. H. Prevalence of metabolic syndrome among US adults: finding from the third National Health and Nutrition Examenation Survey. J. A. M. A. 2002; 287: 356-359.
  4. K-DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney Disease Outcome Quality Initiative. Am. J. Kidney Dis. 2002; 39: 1-266.
  5. Lesley A. S., Coresh J., Greene T., Levey A. S. Assessing kidney function - measured and estimated glomerular filtration rate. N. Engl. J. Med. 2006; 354: 2473-2483.
  6. Фомин В. В. Хроническая болезнь почек. В кн.: Шилов Е. М. (ред.) Нефрология: Учеб. пособие для послевузовского образования. М.: ГЭОТАР-Медиа; 2007; гл. 29: 599-601.
  7. Chen J., Muntner P., Hamm L. L. et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann. Intern. Med. 2004; 140: 167-174.
  8. Земченков А. Ю., Томилина Н. А. "К|DOQI" обращается к истокам хронической почечной недостаточности. Нефрол. и диализ 2004; 6 (3): 204-220.
  9. Tuttle K. R. Renal manifestations of the metabolic syndrome. Nephrol. Dial. Transplant. 2005; 20 (5): 861-864.
  10. Best P. J. M., Holmes D. R. Chronic kidney disease as a cardiovascular risk factor. Am. Heart J. 2003; 145 (3): 383-386.
  11. Sarnak M. J., Levey A. S., Schoolwerth A. C. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-1065.
  12. Go A., Chertow G., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004; 351: 1296-1305.
  13. Weiner D. E., Tighiouart H., Amin M. G. et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J. Am. Soc. Nephrol. 2004; 15: 1307-1315.
  14. Coresh J., Astor B., Sarnak M. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr. Opin. Nephrol. Hypertens 2004; 13: 73-81.
  15. William F. C., Macnab J. J., Chen S. J. et al. Evaluation of GFR estimating equations in the general community: Implications for screening. Clin. J. Am. Soc. Nephrol. 2006; 1: 787- 795.
  16. Wesson L. Physiology of the human kidney. New York: Grune & Stratton, 1969.
  17. Наточин Ю. В. Основы физиологии почки. Л.: Медицина; 1982. 29-34.
  18. Mohanram A., Toto R. Measurement of kidney function. In: Pereira B. J. G., Sayegh M. H., Blake P. G., eds. Chronic kidney disease, dialysis, and transplantation: a companion to Brenner and Rector's the kidney. Philadelphia: Saunders; 2005: 20-30.
  19. Pollock C., Gyory A. Z., Hawkins T. et al. Comparison of simultaneous renal clearances of true endogenous creatinine and subcutaneously administered lothalamate in man. Am. J. Nephrol. 1995; 15 (4): 277-282.
  20. Кутырина И. М. Функции почки, методы оценки, клиническое значение. В кн.: Шилов Е. М. (ред.) Нефрология: Учеб. пособие для послевузовского образования. М.: ГЭОТАР-Медиа; 2007; гл. 4: 58-63.
  21. Lesley A. S., Coresh J., Greene T., Levey A. S. Assessing kidney function - measured and estimated glomerular filtration rate. N. Engl. J. Med. 2006; 354 (23): 2473-2483.
  22. Marouf R., Mojiminiyi O., Abdella N. et al. Comparison of renal function markers in Kuwaiti patients with sickle cell disease. J. Clin. Pathol. 2006; 59: 345-351.
  23. Тареева И. Е. (ред.). Нефрология: Руководство для врачей. М.: Медицина, 2000.
  24. Кутырина И. М. Методы исследования функционального состояния почек. В кн. Тареева И. Е. (ред.). Нефрология. М.: 2000; гл. 5: 90-92.
  25. Levey A. S. Measurement of renal function in chronic renal disease. Kidney Int. 1990; 38: 167-184.
  26. Shemesh O., Golbetz H., Kriss J. P., Myers B. D. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985; 28: 830-838.
  27. Stevens L. A., Levey A. S. Measurement of kidney function. Med. Clin. N. Am. 2005; 89: 457-473.
  28. Levey A. S., Bosch J. P., Lewis J. B. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann. Intern. Med. 1999; 130: 461-470.
  29. Myers G. L., Miller W. G., Coresh J. et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin. Chem. 2006; 52: 5-18.
  30. Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
  31. Сагинова Е. А., Галлямов М. Определение скорости клубочковой фильтрации - необходимый скрининговый метод обследования терапевтических больных. Врач 2007; 6: 35-37.
  32. Stevens L. A., Levey A. S. Frequently asked questions about GFR estimates. New York: National Kidney Foundation, 2004 (http://www.kidney.org/professionals/kls/pdf/faq_gfr.pdf).
  33. Gault M. H., Longerich L. L., Harnett J. D. et al. Predicting glomerular function from adjusted serum creatinine. Nephron 1992; 62: 249-256.
  34. Sawyer W. T., Canaday B. R., Рое T. E. et al. A multicenter evaluation of variables affecting the predictability of creatinine clearance. Am. J. Clin. Pathol. 1982; 78: 832-838.
  35. Hallynck T., Soep H. H., Thomis J. et al. Prediction of creatinine clearance from serum creatinine concentration based on lean body mass. Clin. Pharmacol. Ther. 1981; 30: 414-421.
  36. Rustard P., Felding P., Franzsen L. et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand. J. Clin. Lab. Invest. 2004; 64: 271-284.
  37. Delanaye P., Radermecker R. P., Rorive M. et al. Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol. Dial. Transplant. 2005; 20 (10): 2024-2028.
  38. Geddes C. C., Woo Y. M., Brady S. Glomerular filtration rate - what is the rationale and justification of normalizing GFR for body surface area? Nephrology Dialysis Transplantation published online on October 2, 2007 (http://ndt.oxfordjournals.org/cgi/content/full/gfm662v1)
  39. Gibson S., Numa A. The importance of metabolic rate and the folly of body surface area calculations. Anaesthesia 2003; 58: 50-55.
  40. Schmieder R. E., Beil A. H., Weihprecht H., Messerli F. H. How should renal hemodynamic data be indexed in obesity? J. Am. Soc. Nephrol. 1995; 5: 1709-1713.
  41. Anastasio P., Spitali L., Frangiosa A. et al. Glomerular filtration rate in severely overweight normotensive humans. Am. J. Kidney Dis. 2000; 35: 1144- 1148.
  42. Chagnac A., Weinstein T., Korzets A. et al. Glomerular hemodynamics in severe obesity. Am. J. Physiol. 2000; 278: F817- F822.
  43. Chagnac A., Weinstein T., Herman M. et al. The effects of weight loss on renal function in patients with severe obesity. J. Am. Soc. Nephrol. 2003; 14: 1480-1486.
  44. Rule A. D., Larson T. S., Bergstralh E. J. et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann. Intern. Med. 2004; 141: 929-937.
  45. Poggio E. D., Wang X., Greene T. et al. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J. Am. Soc. Nephrol. 2005; 16: 459-466.
  46. Praga M., Hernandez E., Morales E. et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2001; 16: 1790-1798.
  47. Bailey R. R., Lynn K. L., Burry A. F., Drennan C. Proteinuria, glomerulomegaly and focal segmental glomerulosclerosis in a grossly obese man with obstructive sleep apnea syndrome. Aust. N. Z. J. Med. 1989; 10: 470-472.
  48. Сагинова Е. А., Федорова Е. А., Фомин В. В. и др. Формирование поражения почек у больных ожирением. Тер. арх. 2005; 5: 36-41.
  49. Chagnac A., Herman M., Zingerman В., Erman A. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol. Dial. Transplant. 2008; 23: 3946-3952.
  50. Palatini P., Mormino P., Dorigatti F. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: The HARVEST. Kidney Int. 2006; 70: 578-584.
  51. Silveiro S. P., Friedman R., de Azevedo M. J. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabet. Care 1996; 19 (2): 171-174.
  52. Yip J. W., Jones S. L., Wiseman M. J., Hill C. Glomerular hyperflltration in the prediction of nephropathy in IDDM: a 10-year follow-up study diabetes. Diabet. Care 1996; 45 (12): 1729-1733.
  53. Tomaszewski M., Charchar F. J., Maric C. et al. Glomerular hyperflltration: A new marker of metabolic risk. Kidney Int. 2007; 71: 816-821.
  54. Tantravahi J. R., Srinivas T. R., Johnson R. J. Hyperfiltration: a sign of poor things to come in individuals with metabolic syndrome. Nature Clin. Pract. Nephrol. 2007; 3: 474-475.
  55. Levey A. S., Greene T., Kusek J., Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. J. Am. Soc. Nephrol. 2000; 11: 155A-155A.
  56. Levey A. S., Coresh J., Greene T. et al. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J. Am. Soc. Nephrol. 2005; 16: 69A-69A.
  57. Wetzels J. F. M., Kiemeney L. A. L. M., Swinkels D. W. et al. Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study. Kidney Int. 2007; 72; 632-637.
  58. Coresh J., Stevens L. A. Kidney function estimating equations: where do we stand? Curr. Opin. Nephrol. Hypertens. 2006; 15: 276-284.
  59. Coresh J., Eknoyan G., Levey A. S. Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J. Am. Soc. Nephrol. 2002; 13: 2811- 2812.
  60. Delanaye P., Cavalier E., Chapelle J. P., Krzesinski J. M. Importance of the creatinine calibration in the estimation of GFR by MDRD equation. Nephrol. Dial. Transplant. 2006; 21: 1130.
  61. Zuo L., Ma Y. C., Zhou Y. H. et al. Application of GFR-estimating equations in Chinese patients with chronic renal disease. Am. J. Kidney Dis. 2005; 45: 463-472.
  62. Teruel J. L., Sabater J., Galeano C. et al. The Cockroft-Gault equation is better than the MDRD equation for estimating glomerular filtration rate in patients with advanced chronic renal failure. Nefrologia 2007; 27 (3): 314-320.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies